NewAmsterdam Pharma Company N.V.NAMSNASDAQ
Loading
Revenue Growth Under PressureDecelerating
Percentile Rank20
Studio
Year-over-Year Change

Year-over-year revenue growth rate

Latest
-50.61%
↓ 451% vs avg
Percentile
P20
Within normal range
Streak
1 yr
Consecutive declineDecelerating
Average
14.41%
Historical baseline
PeriodValue
2025-50.61%
2024223.37%
2023-86.28%
20220.00%
20210.00%
20200.00%